Indeed, small molecule inhibitors targeting SCF-SKP2-CKS1 are able to stabilise p27 protein levels and block cancer cells in G2/M phase of the cell cycle, leading to cell death, rather than cell cycle arrest (8, 26, 27). Here, CKS1B is linked to cancer.